Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine
about
Sex differences in Parkinson's diseaseNeuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson's Disease: Involvement of the PI3K/Akt/GSK3β PathwaySuicide HSVtk gene delivery by neurotensin-polyplex nanoparticles via the bloodstream and GCV Treatment specifically inhibit the growth of human MDA-MB-231 triple negative breast cancer tumors xenografted in athymic mice.Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigraLoss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activationPathway-focused PCR array profiling of enriched populations of laser capture microdissected hippocampal cells after traumatic brain injuryNeurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease.Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors.Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease.miR-135b Plays a Neuroprotective Role by Targeting GSK3β in MPP+-Intoxicated SH-SY5Y Cells.Neurturin overexpression in dopaminergic neurons induces presynaptic and postsynaptic structural changes in rats with chronic 6-hydroxydopamine lesion.Expression of Gas1 in Mouse Brain: Release and Role in Neuronal Differentiation.Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease.Glycogen Synthase Kinase-3β Regulates Equilibrium Between Neurogenesis and Gliogenesis in Rat Model of Parkinson's Disease: a Crosstalk with Wnt and Notch Signaling.Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo.Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide.Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment.
P2860
Q27025107-3116E530-BCAA-4375-8254-4B68E7CDE00EQ28390865-DB6AD04F-0DF4-4960-8E9A-A861F21DC7CDQ33604560-50ECD0A1-E596-4DE2-BAEF-293398CB6EFDQ34768987-25F6A6EB-9474-4C5D-859B-29333E20B355Q35177092-B47EB790-92C1-4E12-8557-24C6F9ABAA47Q35643108-14332211-9467-4384-A0BC-C90EECD686E3Q35878528-A0CE0BAF-865E-4722-AD23-419E8423D824Q38260925-7CD5514F-8B76-444D-9344-28A410C702B9Q38731068-3F95FE2C-E546-4D5B-ADA6-B1219A917776Q39284027-F3DB513E-EBA2-4A93-99DC-02FFBF28015FQ42177761-665EDA76-7795-4895-9C62-7837B4BF43EBQ47162932-FA85EF61-5F7E-4EF9-A5E5-CE15E26ABB1BQ47433086-F899B441-9CC6-4A24-8691-B1263B0BA1EBQ47907310-5D9910BC-D6CE-434D-ACF2-60DAAB0F43B2Q48256484-34A063A6-A536-47B2-9D37-FEBDF1F659ADQ51242782-0A19DE9E-23DE-4318-A122-9A1244065988Q52579561-B517D96E-A585-44AB-893F-81E7D69FCCDBQ54981317-29B289E8-6BC2-463A-BA9D-F9294E6749BAQ55396058-5B6A7641-12D0-4F56-AC7E-0BC371612E04
P2860
Activation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamine
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Activation of GSK-3β and caspa ...... injection of 6-hydroxydopamine
@ast
Activation of GSK-3β and caspa ...... injection of 6-hydroxydopamine
@en
Activation of GSK-3β and caspa ...... injection of 6-hydroxydopamine
@nl
type
label
Activation of GSK-3β and caspa ...... injection of 6-hydroxydopamine
@ast
Activation of GSK-3β and caspa ...... injection of 6-hydroxydopamine
@en
Activation of GSK-3β and caspa ...... injection of 6-hydroxydopamine
@nl
prefLabel
Activation of GSK-3β and caspa ...... injection of 6-hydroxydopamine
@ast
Activation of GSK-3β and caspa ...... injection of 6-hydroxydopamine
@en
Activation of GSK-3β and caspa ...... injection of 6-hydroxydopamine
@nl
P2860
P1433
P1476
Activation of GSK-3β and caspa ...... injection of 6-hydroxydopamine
@en
P2093
Daniel Martinez-Fong
Maria E Mendoza-Garrido
P2860
P304
P356
10.1371/JOURNAL.PONE.0070951
P577
2013-08-05T00:00:00Z